<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings</dc:title>
  <dc:creator>Cressey, Tim R.</dc:creator>
  <dc:creator>Plipat, Nottasorn</dc:creator>
  <dc:creator>Fregonese, Federica</dc:creator>
  <dc:creator>Chokephaibulkit, Kulkanya</dc:creator>
  <dc:date>2007</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/PAR00005532</dc:identifier>
  <dc:identifier>PAR00005532</dc:identifier>
  <dc:identifier>Cressey Tim R., Plipat Nottasorn, Fregonese Federica, Chokephaibulkit Kulkanya. Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings. 2007, 3 (3),  347-361</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>